2013

USAID Office of Inspector General and La Fondation Héritage pour Haïti Launch Anti-Corruption Hotline (Creole)

WASHINGTON, DC - Biwo Enspektè Jeneral nan Ajans Amerikèn pou Devlòpman Entènasyonal (USAID OIG) ak Fondasyon Eritaj pou Ayiti (LFHH), branch ki reprezante Transparancy International (TI) nan peyi Dayiti, anonse fonksyonnman yon liy telefòn dirèk pou lite kont koripsyon an Ayiti.

USAID Office of Inspector General and La Fondation Héritage pour Haïti Launch Anti-Corruption Hotline (French)

WASHINGTON, DC - Le Bureau de l'Inspecteur Général de l'Agence Américaine pour le Développement International (USAID OIG), et la Fondation Héritage pour Haïti (LFHH),  le chapitre haïtien de Transparency International (TI), ont lancé le fonctionnement d’un numéro d’appel direct pour lutter contre la corruption en Haiti.

Former Deputy Director of USAID Contractor Sentenced To 51-Month Prison Term for Embezzling More Than $1 Million

WASHINGTON - Mark Adams, a former deputy director at a private contractor that did business with the U.S. Agency for International Development (USAID), was sentenced today to 51 months in prison on a federal conspiracy charge stemming from the embezzlement of more than $1 million from a program meant to address global health problems.

One Former Development Worker Sentenced for Embezzlement and Fraud, Another Acquitted

KABUL, AFGHANISTAN – A former contractor for a recently completed U.S. Agency for International Development (USAID) project in Afghanistan has been sentenced to two-and-a-half years in prison and a $9,500 fine.

Noor Anwarzai, 36, was sentenced by Afghanistan’s Special Anti-Corruption Tribunal on April 8, 2013. The Tribunal found Mr. Anwarzai guilty of violating Afghan Penal Code Article 268, regarding embezzlement of funds and Article 310 regarding the forgery of official documents.

Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees to Pay $500 Million to Resolve False Claims Allegations, cGMP Violations, and False Statements to the FDA

WASHINGTON – In the largest drug safety settlement to date with a generic drug manufacturer, Ranbaxy USA Inc., a subsidiary of Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited, pleaded guilty today to felony charges relating to the manufacture and distribution of certain adulterated drugs made at two of Ranbaxy’s manufacturing facilities in India, the Justice Department announced today. Ranbaxy also agreed to pay a criminal fine and forfeiture totaling $150 million and to settle civil claims under the False Claims Act and related State laws for $350 million.

Contrack International Inc. Agrees to Pay $3.5 Million to Resolve False Claims Act Allegations

Contrack International Inc., a global design and construction company headquartered in McLean, Va., has agreed to pay $3.5 million to settle allegations that it submitted false claims in connection with U. S. Agency for International Development (USAID) contracts, the Justice Department announced today.

Former USAID Senior Official to Pay Civil Penalty for Alleged Conflict of Interest Violation

David Ostermeyer, who retired from the U.S. Agency for International Development (USAID) in 2012, will pay the government a $30,000 penalty to settle allegations that he participated in a matter in which he had a financial interest that conflicted with his duties when he was Chief Financial Officer of the agency, the Justice Department announced today.